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Development Vof a fertilizable oocyte is a complex process that relies on the precise temporal and spatial expression of specific genes in germ
cells and in surrounding somatic cells. Since female mice null for Taf4b, a TBP associated factor, are sterile, we sought to determine when during
follicular development this phenotype was first observed. At postnatal day 3, ovaries of Taf4b null females contained fewer (P < 0.01) oocytes
than ovaries of wild type and heterozygous Taf4b mice. However, expression of only one somatic cell marker Foxl2 was reduced in ovaries at day
15. Despite the reduced number of follicles, many proceed to the antral stage, multiple genes associated with granulosa cell differentiation and
oocyte maturation were expressed in a normal pattern, and immature Taf4b null females could be hormonally primed to ovulate and mate.
However, the ovulated cumulus oocyte complexes from the Taf4b null mice had fewer (P < 0.01) cumulus cells, and the oocytes were functionally
abnormal. GVBD and polar body extrusion were reduced significantly (P < 0.01). The few oocytes that were fertilized failed to progress beyond
the two-cell stage of development. Thus, infertility in Taf4b null female mice is associated with defects in early follicle formation, oocyte
maturation, and zygotic cleavage following ovulation and fertilization.
D 2005 Elsevier Inc. All rights reserved.Keywords: TAF4b; Oocyte; Primordial follicle; Foxl2; Granulosa cells; Cumulus oocyte complex; Fertilization; Zygotic genome activation; Ovary; TBPIntroduction
Ovarian follicle development is a complicated process that
requires the transcription of many genes that must be expressed
in specific temporal and spatial locations within the gonadal
somatic cells and germ cells (Richards et al., 2002b).
Expression of each gene is controlled by combinatorial
transcription factor binding sites within promoters. Recruitment
of transcription factors to these binding sites can sequester co-
activators or co-repressors to facilitate the recruitment of the
RNA polymerase II holoenzyme. The pre-initiation complex
(PIC) that recruits RNA polymerase II to promoters consists of
a variety of subunits including TFIID. TFIID contains TBP (the
TATA-binding protein) and several TAFs (TBP associated
factors) (Hochheimer and Tjian, 2003).
One of these, TAF4b (originally TAFII105), was found be
expressed at high levels in human B cells (Dikstein et al.,0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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this factor is required for gonadal development but not immune
function (Falender et al., 2005; Freiman et al., 2001, 2002).
Specifically, we have shown that TAF4b is essential in male
mice for the proliferation of spermatogonia in the neonatal
testis (Falender et al., 2005). Taf4b null male mice are initially
fertile, but then seminiferous tubules become devoid of sperm
resulting in complete loss of fertility by 11 weeks of age. The
developmental basis of this phenotype was traced to a defect
occurring between postnatal day 0 and day 3. TAF4b appears
to be required for the expression of spermatogonial genes
including stimulated by retinoic acid gene 8 (Stra8), PLZF
(Zbtb1), and the Ret oncogene (Ret) (Falender et al., 2005). In
contrast to males, Taf4b null females are completely infertile
and present a complex phenotype (Freiman et al., 2001). To
identify specific stage(s) of follicle development at which
TAF4b is critical and to determine if female germ cell
development might be defective in the female as in the male,
additional analyses have been done with particular focus on
key stages of early postnatal ovarian development and oocyte
maturation.88 (2005) 405 – 419
www.e
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and migrate to the gonad where they enter meiosis around 13.5
days post-coitum (d.p.c.) and arrest in prophase I of meiosis by
16.5 d.p.c. (McLaren, 2003). At birth, meiotically arrested
oocytes are organized into structures called cysts that consist of
several conjoined germ cells and surrounded by somatic cells
(Pepling et al., 1999). Between postnatal day 0 and postnatal
day 3, these germ cell cysts breakdown as primordial follicles
form (Pepling and Spradling, 2001). During primordial follicle
formation, oocytes grow in size and become surrounded by a
single layer of squamous granulosa cells. Between postnatal
day 3 and day 8, some primordial follicles initiate growth and
become primary follicles that are characterized by further
increases in oocyte size and granulosa cells that become
cuboidal in shape (Kezele et al., 2005).
Primary follicles respond to pituitary and intra-ovarian
hormones to become secondary follicles and then pre-ovulatory
follicles. Around the time of ovulation, the oocyte undergoes the
process of meiotic maturation: germinal vesicle breakdown
(GVBD) occurs, the oocyte progresses from the dictyate stage of
prophase I to metaphase I of meiosis, chromosomes become
condensed, the spindle body forms as microtubules reorganize,
and polar body emission occurs (Wasserman and Albertini,
1994). Following fertilization, the haploid maternal and paternal
pronuclei each undergo one round of DNA replication leading to
the development of the 2-cell stage zygote (Hamatani et al.,
2004). By this time, 90% of the maternal RNA has degraded
setting the stage for zygotic genome activation (ZGA) (Schultz,
2002). During ZGAwhich occurs between the 1-cell and 2-cell
stage of development in mice, the zygotic (both paternal and
maternal) genome begins active transcription, and the translation
of RNA is initiated (Nothias et al., 1995).
The studies described herein show that loss of Taf4b causes
complete infertility in the female due to developmental defects
observable as early as postnatal day 3 when the number of
oocytes is markedly reduced. Although follicular development
can proceed and ovulation can be hormonally stimulated, many
Taf4b null oocytes fail to release a polar body, and the few
oocytes that are fertilized fail to develop beyond the 2-cell
stage. These results suggest that defects in somatic cell–oocyte
interactions during the follicle formation and oocyte matura-
tion, including ZGA, cause the infertility in Taf4b null females.
Materials and methods
Animals
Mice null for Taf4b were generated by an insertion of a neomycin resistance
cassette in the reverse orientation into the 6th exon of the Taf4b gene as
previously described (Freiman et al., 2001). Heterozygous mice were back-
crossed to the inbred C57BL/6 strain (Harlan, Indianapolis, IN). Mice were
maintained on a 14L:10D cycle with free access to food and water in the
vivarium at Baylor College of Medicine. Mice were maintained in accordance
with the NIH Guide for the Care and Use of Laboratory Animals with
Institutional oversight by Baylor College of Medicine.
Hormone treatments and fertilization experiments
Immature female C57BL/6 (d25) mice were obtained from Harlan
Sprague–Dawley, Inc. (Indianapolis, IN) or from heterozygous crossings andinjected with 5 IU of pregnant mare serum gonadotropin (PMSG, Gestyl)
purchased from Professional Compounding Center of America (Houston, TX)
to stimulate follicle growth followed 48 h later with 5 IU of human chorionic
gonadotropin (hCG, Pregnyl) from Organon Special Chemicals (West Orange,
NJ) to stimulate ovulation and luteinization.
Females used for hormone treatment studies were treated with the same
regime listed above (5 IU PMSG followed by 5 IU of hCG) and sacrificed at
various time points. For fertilization experiments, wild type, heterozygous, and
Taf4b null females were treated with PMSG followed by hCG, and then each
female was placed in a cage with an individual wild type male. On the
following morning, vaginal plugs were observed, and, immediately or 24 h later,
COCs were collected from the oviducts, and oocytes were isolated. Oocytes
(unfertilized and fertilized) were stained with the DNA dye Drac55 (generously
provided by M. Mancini, Baylor College of Medicine) and imaged using the
confocal microscope (Zeiss LSM 510 Laser Confocal Microscopy, Carl Zeiss
Inc., Thronwood, NY). Other oocytes were fixed with 4% paraformaldehyde
and immunostained for tubulin as described below.
Histology and immunohistochemistry
Ovaries were collected and fixed in 4% paraformaldehyde or Bouin’s fixative
overnight, dehydrated in 70% ethanol, and embedded in paraffin. Sectioned
tissues were dehydrated and stained with hematoxylin and eosin then re-
dehydrated and mounted. The cellular and subcellular localization of germ cell
nuclear antigen 1 (GCNA1, dilution 1:1) (generously provided by George C.
Enders, University of Kansas; Enders and May, 1994) and TAF4b (1:500)
(generously provided by KenGeles, University of California, Berkeley; Falender
et al., 2005) were analyzed by immunostaining. Bouin’s fixed sections (7 Am)
embedded in paraffin were deparaffinized in xylene washes and quenched with
3% hydrogen peroxide in methanol. Following re-hydration, sections were
incubated with 10 mM sodium citrate (pH 6.0) at 90-C for 20 min and cooled to
room temperature. Sections were then incubated with nonimmune goat serum
(20% for GCNA1 and 5% for TAF4b) to block nonspecific sites followed by
incubation with the GCNA1 monoclonal antibody at 33-C for 90 min or with
polyclonal antibodies against TAF4b overnight at 4-C. For GCNA1, horseradish-
peroxidase-conjugated anti-rat IgMA diluted to a concentration of 1:450 was
applied for 60 min at room temperature (Pierce Biotechnology, Inc., Rockford,
IL). For TAF4b, the Vectastain ABC kit (Vector Labs, Burlingame, CA) and
manufacturer’s instructions were followed. Finally, sections were incubated with
DAB substrate (3,3V-diaminobenzidine) (Vector Labs, Burlingame, CA), counter-
stained with hematoxylin, dehydrated, and mounted.
Cumulus oocyte complex isolation
For isolation of unexpanded cumulus oocyte complexes, females were
sacrificed 48 h after treatment with PMSG. Ovaries were punctured using 26-
gauge needles, and unexpanded COCs were isolated manually. Unexpanded
COCs were placed in expansion medium (MEMwith Earle’s salts supplemented
with 25 mM HEPES, 0.25 mM sodium pyruvate, 3 mM l-glutamine, 1 mg/ml
BSA, plus 1% FBS) and cultured overnight with or without FSH (100 ng/ml) at
37-C in a humidified incubator (95% air, 5% CO2). On the following morning,
COCs were observed and scored as ‘‘good’’ expansion (10 or more layers of
cumulus cells), ‘‘poor’’ expansion (2–9 layers of cumulus cells), or no expansion
(denuded oocyte or primary follicle). COCs were viewed using standard light
microscopy.
For isolation of expanded COCs, PMSG-hCG primed females were
sacrificed 24 h after treatment with hCG, and ovulated COCs were collected
from the oviducts, immediately frozen, and stored at 80-C in preparation for
RNA isolation.
Germ cell counting
To determine the relative number of oocytes present in the ovaries of neonatal
mice at D0, D3, and D8, paraffin-embedded tissues were serially sectioned at a
thickness of 5 Am and stained with hematoxylin and eosin. Oocytes from every
fifth serial section were counted and classified as primordial or primary. For each
group, 6 ovaries were counted (Rajkovic et al., 2004).
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TUNEL assays were performed on Bouin’s fixed paraffin-embedded
sections according to manufacturer’s instructions using the ApopTag Plus
Peroxidase In Situ Apoptosis Detection Kit (Serologicals Corporation,
Norcross, GA).
Hormone assays
Blood was drawn by cardiac puncture. Serum was separated by centrifuga-
tion (2 min, 16,000 rpm) in microtainer brand tubes (Becton Dickinson, Franklin
Lakes, New Jersey), frozen, and stored at80-C. Radioimmunoassays for FSH,
LH, testosterone (T), estradiol (E), and progesterone (P) were performed by the
Ligand Assay and Analysis Core, SCCPRR (University of Virginia), as
previously described (Fallest et al., 1995; Gay et al., 1970) or by using the
commercially available testosterone RIA or progesterone RIA kit from
Diagnostic Products Corporation (Los Angeles, CA) or the estradiol RIA kit
from Diagnostic Systems Laboratories (Webster, TX).
RNA isolation
Whole ovary RNA was obtained by tissue homogenization in TRIzol
reagent (Line Technologies, Inc., Gaithersburg, MD) followed by RNA
precipitation in isopropanol. Recovered RNA was then resuspended in
DEPC-treated water and verified as DNA free by PCR. For cumulus oocyte
complexes and neonatal ovaries, RNAwas isolated using the RNeasy Kit from
Qiagen (Valencia, CA). RNA was quantitated and stored at 80-C until use.
RT-PCR analyses
Total RNA (300 ng) was reverse transcribed using poly-dT (Amersham
Pharmacia Biotech, Newark, NJ) and avian myeloblastosis virus-reverse
transcriptase (Promega Corp., Madison, WI) at 42-C for 75 min and 95-C from
5 min. PCR primers were generated using a web-based prediction algorithm
http://www.genome.wi.mit.edu/genomesoftware/other/primer3.html. The
cDNAproductswere amplified using Taq Polymerase (PromegaCorp.,Madison,
WI). Alpha-P32 CTP was added to the reaction mixture for incorporation, and
reactions were completed 25–30 cycles of PCR at 95-C for 30 s, 59-C for 45 s,
and 72-C for 60 s. The amplified cDNA products were resolved on a 5%
polyacrylamide gel, which was dried and exposed to film. The radioactive PCR
product bands were quantified by using a Storm 860 PhosphoImager (Molecular
Dynamics, Inc., Sunnyvale, CA). To determine the linear range of amplification
for specific mRNAs, 300 ng of RNAwas reverse transcribed and amplified in a
range of cycle numbers. The primer pairs used are listed in Supplemental Table 1.
Sequences for the amplified PCR products were verified by subcloning and
sequencing at the Baylor College of Medicine Sequencing Core (Houston, TX).
In situ hybridization
Ovaries and testes were fixed in 4% paraformaldehyde in PBS overnight at
4-C before dehydration and paraffin embedding. Slides were prehybridized,
hybridized with sense or antisense probes, washed, exposed, and developed as
previously described (Robker and Richards, 1998). The probes used were for
cholesterol side-chain cleavage cytochrome P450 (P450scc; Cyp11a1) (gene-
rously provided by Keith Parker), Lrh-1 (Nr5a2) (Falender et al., 2003), and
inhibinhA (Inhba) which was cloned into the PCR-4 Topo vector (Invitrogen,
Carlsbad, CA) following amplification using the following oligonucleotides
listed in the 5V to 3V orientation: inhibinhA (sense): tggagtgtgatggcaaggtc,
inhibinhA (antisense): agccacactcctccacaatc.
Analyses of meiosis: GVBD, polar body extrusion, and spindle
formation
For oocyte studies, female mice were treated with 5 IU of PMSG
followed by 5 IU of hCG for 24 h as described above. Cumulus oocyte
complexes were isolated. Wild type and heterozygous COCs were placed inhyaluronidase (Sigma) 18 IU/ml for 3 min and then subjected to gentle
vortexing for 1 min. Taf4b null COCs were placed in hyaluronidase 18 IU/
ml and immediately vortexed to dissociate the cumulus cells and then
collected by centrifugation (0.7 rcf for 1 min). Denuded oocytes were
placed on poly-lysine-coated slides and fixed with 4% paraformaldehyde for
30 min. Following permeabilization in 0.5% NP-40, oocytes were blocked
using the Mouse on Mouse (M.O.M.) Peroxidase Kit (Vector Labs,
Burlingame, CA) blocking reagent. Immunofluorescence was conducted
using an anti-acetylated tubulin antibody (Sigma, T-6793) at a concentration
of 1:500 incubated overnight at 4-C and secondary antibody goat anti-
mouse Alexa Fluor-594 at a concentration of 1:200 (Molecular Probes,
Eugene, Oregon). Oocytes were mounted in Vectashield mounting media
containing DAPI to stain DNA (Vector Labs, Burlingame, CA).
Statistics
All statistics were analyzed with Prism GraphPad software (San Diego,
CA). For all data sets, standard t tests or 1-way and 2-way ANOVAwere used,
and standard error of means was calculated as appropriate. Statistical
significance was defined as P < 0.05.
Results
To understand in more detail the underlying causes of ovarian
dysfunction in Taf4b null females, we first sought to determine
when this transcriptional regulator is expressed during early
stages of ovarian development. Semiquantitative RT-PCR using
oligonucleotides designed against Taf4b shows that Taf4b
mRNA is expressed in the neonatal ovary as early as the day
of birth, D0 (Fig. 1A). Expression persisted in the postnatal
ovary through D25 at relatively consistent levels. Taf4b
transcripts were also abundantly expressed in oocytes which
has been shown by the Genome Institute of the Novartis
Research Foundation (data not shown and http://symatlas.gnf.
org/SymAtlas/). TAF4b shows significant homology to TAF4
(Dikstein et al., 1996). While Taf4b is enriched in the gonads,
Taf4 expression is more ubiquitous and found in non-gonadal
tissues (Freiman et al., 2001). To determine if expression of
either Taf4b or Taf4 was hormonally regulated in the ovary,
semiquantitative RT-PCR was conducted using ovarian samples
isolated from immature (D25) mice prior to and after treatment
with PMSG to stimulate follicle growth followed by hCG to
stimulate cumulus expansion, ovulation, and luteinization.
mRNA levels of either Taf4b (Fig. 1B) or Taf4 (Fig. 1C) were
not changed significantly by hormone treatment, indicating that
Taf4b and Taf4 appear to have overlapping patterns of
expression in the ovary at the level of mRNA.
To determine the cell types in which TAF4b protein is
expressed, immunohistochemistry was performed using a
polyclonal antibody raised against TAF4b. As shown, TAF4b
protein is detected in germ cells but not somatic cells in the
embryonic ovary at 14.5 day post-coitum (d.p.c.) (Fig. 1D). At
postnatal day 2, nuclear TAF4b protein persists in oocytes (Fig.
1E) but was not observed in the somatic cells. To determine the
specificity of the antibody, we show that TAF4b protein was
not detected in Taf4b null ovaries at postnatal day 2 (Fig. 1F) or
at day 25 (data not shown). The apparent absence of TAF4b
protein in the somatic cells was surprising since previous data
showed selective expression of Taf4b in granulosa cells of the
adult ovary (Freiman et al., 2001). The apparent discrepancy in
Fig. 1. Taf4b is expressed throughout the developing ovary. Semiquantitative RT-PCR was performed using oligonucleotides designed against Taf4b (A and B) or
Taf4 (C) using RNA isolated from wild type ovaries of neonatal (day 0–day 15) and immature (day 25) females untreated or treated with PMSG followed by hCG.
Values were normalized to the internal control L19. Fold changes are reported and represent three separate experiments. Immunohistochemistry was performed using
a polyclonal antibody against TAF4b in ovaries isolated from wild type embryonic ovaries (D), wild type neonatal (E), and Taf4b null neonatal ovaries (F).
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associated with follicle development or with posttranscriptional
regulation of Taf4b at the level of translation as has been
observed in immune cells (Silkov et al., 2002). Alternatively,
the immunoreactive epitope of TAF4b protein may be masked
in granulosa cells due to fixation procedures or the binding of
TAF4b to other intracellular proteins, as has been observed
with other antibodies (Gonzalez-Robayna et al., 1999). TAF4b
has also been localized within the cytoplasm as well as nuclei
of other cells (Silkov et al., 2002). If this also occurs in
granulosa cells, it might render detection less sensitive and
effective.
TAF4b null ovaries appear normal at embryonic day 14.5
Since developmental defects in the Taf4b null males are
observed prior to puberty (Falender et al., 2005) and because
TAF4b protein is expressed in germ cells of the wild type ovary
as early as 14.5 d.p.c., we sought to determine if Taf4b null
females exhibited phenotypic abnormalities prior to birth.
Staining of wild type and Taf4b null 14.5 d.p.c. ovaries with
a monoclonal antibody against germ cell nuclear antigen 1
(GCNA1) revealed no overt histological abnormalities. In both
heterozygous and Taf4b null ovaries, numerous germ cells that
have not yet been organized into follicles can be observed
throughout the ovary (Figs. 2A–B).To investigate further the possibility of an embryonic
phenotype in Taf4b null ovaries, semiquantitative RT-PCR
was performed using RNA isolated from ovaries of wild type,
heterozygous, and Taf4b null females at 14.5 d.p.c. Assays
were conducted for genes known to be expressed at this time in
somatic cells including Adamts19, Follistatin (Fst), and Wnt4
(Menke and Page, 2002; Yao et al., 2004) and in germ cells
including Bmp8b, Dmc1, Rarg, and Stra8 (Menke et al., 2003;
Zhao et al., 1996). That all of these genes are expressed equally
in Taf4b null and wild type ovaries at 14.5 d.p.c. suggests that
somatic cell and germ cell function are normal at this time and
that initiation of prophase I does not require TAF4b (Fig. 2C).
To ensure sample purity, RT-PCR was performed for Taf4b. No
Taf4b mRNA was detected in TAF4b null samples. L19 was
used as a loading control.
Taf4b null ovaries appear normal on the day of birth but
exhibit abnormalities at postnatal day 3
To determine if Taf4b null ovaries exhibit phenotypic
abnormalities on the day of birth, ovaries were stained for the
germ cell marker GCNA1. GCNA1 staining of Taf4b null
ovaries on the day of birth (day 0, data not shown) or at postnatal
day 1 revealed no overt histological differences compared to
heterozygous ovaries (Figs. 3A and B). Specifically, on day 1,
oocytes arrested in prophase I of meiosis are localized at the
Fig. 3. Taf4b null ovaries begin to exhibit phenotypic abnormalities at postnatal
day 3. Taf4b heterozygous (A, C, and E) and null (B, D, and F) were
immunostained for GCNA1 on postnatal day 1 (A and B) or postnatal day 3 (C
and D). Oocytes migrating from the cortex of the ovary to the center are
indicated by black arrows in high magnification images of day 3 ovaries (E and
F). Taf4b null ovaries do not have elevated levels of oocyte apoptosis as shown
by TUNEL assays in heterozygous (G) versus null (H) animals. The ovaries
shown from day 3 animals are representative of ovaries from day 0–day 3.
Fig. 2. Taf4b null ovaries appear phenotypically normal at 14.5 d.p.c. (A)
Ovaries from Taf4b heterozygous or (B) Taf4b null females were immunos-
tained for germ cell nuclear antigen 1 (GCNA1). (C) Semiquantitative RT-PCR
was performed using oligonucleotides against genes expressed in somatic cells
(Adamts19, Follistatin, and Wnt4) and in germ cells (Bmp8b, Dmc1, Stra8,
and Rarg). L19 was used as a loading control.
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B). The distribution of oocytes within the ovary appears normal
in Taf4b null females on the day of birth and on day 1.
By day 3 in wild type and heterozygous ovaries, a few
GCNA1-positive oocytes begin to migrate from the cortex to
the center of the ovary. These migratory oocytes grow in size
and become surrounded by somatic cells (Figs. 3C and E). In
Taf4b null ovaries, this migration and growth pattern appears
altered since fewer enlarged oocytes were noted within the
center of the ovary (Figs. 3D and F). Since it is known that
many oocytes in the wild type ovary undergo apoptosis after
birth (Johnson et al., 2004) and since the Taf4b null ovaries
appeared to contain fewer oocytes, TUNEL assays were
conducted using day 0, 1, 2, and 3 ovaries to determine if
the defects observed in Taf4b null ovaries are due to loss of
oocytes. At these time intervals, apoptotic oocytes are observed
in both heterozygous (Fig. 3G, and data not shown) and Taf4b
null ovaries (Fig. 3H; open arrow, and data not shown),
however, Taf4b null ovaries do not exhibit a notable increase in
the number of TUNEL-positive cells at any of these days,
suggesting that the phenotype observed in Taf4b null ovaries is
not due to increased levels of apoptosis.
Taf4b null ovaries contain fewer oocytes at postnatal day 3
To determine if the number of oocytes or primary follicle
formation was altered by loss of Taf4b, the number of oocytes
was counted and classified as present in primordial or primary
follicles. Ovaries from day 0, day 3, and day 8 wild type,
heterozygous, and Taf4b null animals were serially sectioned at a
thickness of 5 Amand stainedwith hematoxylin and eosin. Every
fifth section was used for counting the number of primordial and
primary follicles. All of the follicles in all of the sections weresummed to determine the relative number of primordial follicles,
primary follicles, and total oocytes per ovary.
On the day of birth, Taf4b null ovaries contain comparable
numbers of oocytes compared to wild type and heterozygous
littermates (Fig. 4A). However, at postnatal day 3, Taf4b null
ovaries contain significantly fewer oocytes compared to wild
type and heterozygous ovaries (Fig. 4B). Likewise, at postnatal
day 8, Taf4b null ovaries contain significantly fewer oocytes
than wild type or heterozygous animals (Fig. 4C), and this is
related to the presence of significantly fewer primordial follicles
in Taf4b null ovaries compared to wild type and heterozygous
animals (Fig. 4C). Surprisingly, Taf4b null ovaries contain
comparable numbers of primary follicles compared to wild type
and heterozygous animals (Fig. 4C). Thus, Taf4b null females
contain a higher percentage of primary follicles than wild type or
heterozygous females (Fig. 4D). These data suggest that the
primordial to primary follicle transition is not disrupted but
might actually be enhanced in the absence of Taf4b. However,
the reduced number of oocytes present in the ovary at day 3 and
day 8 clearly shows that defects occur during the formation or
maintenance of primordial follicles. To visualize the primordial
Fig. 4. Taf4b null ovaries contain fewer oocytes at postnatal day 8. (A) Oocytes from ovaries isolated from animals on the day of birth were counted. (B) Oocytes
from ovaries isolated from postnatal day 3 animals were counted. (C) Oocytes from ovaries isolated from postnatal day 8 wild type, heterozygous, and Taf4b null
females were counted and classified as primordial or primary, and the total number of oocytes was summed. (D) The percentage of primary follicles was calculated.
Ovaries from day 8 heterozygous (E) and Taf4b null (F) females were stained with GCNA1.
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ovaries from heterozygous (Fig. 4E) and Taf4b null (Fig. 4F)
females were immunostained with a germ-cell-specific antibody,
GCNA1. As shown, fewer GCNA1-positive cells are observed
at the periphery of the Taf4b null ovary.
Expression of many genes is normal in Taf4b null ovaries at
postnatal day 15
Because primary follicles form in Taf4b null females, we
investigated gene expression in Taf4b null ovaries at postnatal
day 15, a time when ovaries are enriched for primary and
secondary follicles. Analyses of genes expressed in oocytes at
this time included Bard1 (BRCA1 associated RING domain),
Figla (factor in germline alpha, Figa),Kit (cKit), and Zp3 (Zona
Pullucida 3) as well as genes expressed in somatic cells including
Foxl2, Fst, Gjpa1 (Gap junction membrane channel protein
alpha 1, connexin43), Inhba (InhibinhA), Jag2 (Jagged2), Klf4(Kruppel like factor 4), Rara (retinoic acid receptor a), and Rarg
(retinoic acid receptor g) (Ackert et al., 2001; Drummond et al.,
2000; Johnson et al., 2001; Jorgez et al., 2004; Kissel et al., 2000;
Schmidt et al., 2004; Soyal et al., 2000). All genes assayed were
expressed at the same levels in wild type, heterozygous, and
Taf4b null ovaries at postnatal day 15 with the exception of
Foxl2. Foxl2 is expressed in somatic granulosa cells and is
important for the transition from primordial to primary follicles
in the ovary (Ottolenghi et al., 2005; Schmidt et al., 2004; Uda et
al., 2004). Results presented here suggest that expression of
Foxl2 is significantly decreased in both heterozygous and Taf4b
null ovaries compared to wild type controls (Figs. 5A–B).
Taf4b null females have elevated levels of follicle stimulating
hormone prior to puberty
To determine if endocrine abnormalities were associated
with altered follicle growth and maturation in Taf4b null
Fig. 5. Expression of many genes is normal at postnatal day 15 in Taf4b null
ovaries. (A) Whole RNA isolated from 15-day-old wild type, heterozygous,
and Taf4b null ovaries was reverse transcribed. Specific primer pairs were used
to amplify genes. Genes were normalized to the internal control L19. (B)
Quantification of Foxl2 mRNA levels.
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serum was extracted from wild type, heterozygous, and Taf4b
null females before puberty at postnatal days 23–27 and then
in adult females at 7 weeks of age. As early as day 23, Taf4b
null females have elevated levels of follicle stimulating
hormone (FSH) that persist into adulthood (Fig. 6A). Serum
levels of estradiol (E), luteinizing hormone (LH), and
progesterone (P) (Figs. 6B–D) are normal in Taf4b null
females at all ages. The highly variable levels of LH most
likely reflect the random surges that are known to occur in
prepubertal rats (Richards et al., 2002b).Germ cell and somatic cell genes are normally expressed in
hormone primed Taf4b null ovaries
To investigate the expression of genes known to be
important to follicle growth, in situ hybridization and RT-
PCR analyses were done using ovaries and RNA, respectively,
isolated from wild type, heterozygous, and Taf4b null ovaries.
Assays were conducted for genes expressed in somatic cells
that are involved in activin/inhibin signaling, namely, a, hA,
and hB inhibin subunits; FSH signaling, including Cyp19a1
(aromatase), Ccnd2 (cyclin D2), Fshr (follicle stimulating
hormone receptor), and Foxo1 (FKHR); the gap junction gene
Gja1; nuclear hormone receptors and nuclear hormone receptor
co-activators, including Ncoa1 (SRC-1), Nr5a1 (Steroidogenic
factor 1), Nr5a2, Nrip1 (RIP140), and Sirt1 (Sir2) (Britt et al.,
2001; Jeyasuria et al., 2004; Kumar et al., 1997; McBurney et
al., 2003; McKenna and O’Malley, 2000; Richards et al.,
2002c; Robker and Richards, 1998; White et al., 2000). In
addition, a marker of luteal cell function, cholesterol side-chain
cleavage cytochrome P450 (P450scc, Cyp11a1) was also
examined. All of these genes are expressed in Taf4b null
ovaries in a manner similar to that of heterozygous and wild
type Taf4b mice (Figs. 7A–M).
Specifically, in situ hybridization using antisense probes
against the inhibinhA subunit revealed that, in both hetero-
zygous and Taf4b null ovaries isolated from immature (day
21) females, the hA subunit is expressed in growing follicles
(Figs. 7B and D). RT-PCR analyses using RNA from PMSG-
treated ovaries where large follicles are present showed that
expression of the a, hA, and hB subunits is normal (data not
shown). Nr5a2, a transcription factor important for many
genes including those encoding steroidogenic enzymes, has
been shown to be robustly induced in granulosa cells in
response to follicle stimulating hormone (Falender et al.,
2003). In wild type, heterozygous, and Taf4b null ovaries,
Nr5a2 signal is detected specifically in large growing follicles
(Figs. 7F and H) showing appropriate cell-type-specific
expression of Nr5a2 in Taf4b null ovaries. In heterozygous
animals treated with PMSG followed by hCG for 48 h,
expression of Cyp11a1 can be observed in corpora lutea (CLs)
as well as in theca cells (TC) (Fig. 7J). Taf4b null animals
respond to hormone stimulation by developing corpora lutea
that express Cyp11a1 (Fig. 7L). Taken together, these data
show that, in hormonally primed animals, somatic cells within
the ovary appear to properly differentiate into corpora lutea
even in the absence of Taf4b. However, it should also be noted
that there are fewer growing follicles in the immature null
ovary (Fig. 7C), fewer antral follicles in the PMSG-primed
null ovary, and fewer corpora lutea in the luteinized null
ovary, reflecting the reduced numbers of follicles within the
ovaries of the Taf4b null mice.
These results contrast with those published previously
(Freiman et al., 2001) in which mRNA encoding Inhibin hA
(Inhba), cyclin D2 (Ccnd2), Lrh1 (Nr5A2), and aromatase
(Cyp19a1) was markedly reduced in the Taf4b null ovaries
compared to heterozygous littermates. In the studies conducted
herein, the ovaries of the 3-week-old Taf4b null mice contained
Fig. 6. Taf4b null females have elevated FSH levels prior to puberty that persist throughout adulthood. Serum was isolated from day 23, day 25–27, and 7-week-old
wild type, heterozygous, and Taf4b null females, and hormone assays were performed for follicle stimulating hormone (FSH, A), estradiol (B), luteinizing hormone
(LH, C), and progesterone (D). At all time points, Taf4b null females have elevated levels of FSH. All other hormones are present at normal levels in Taf4b null
females. Hormone assays were conducted at the University of Virginia Ligand Assay Core (SCCPRR) as described in Materials and Methods.
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previous study, 8-week-old mice were hormonally primed and
histologically contained many corpora lutea but few follicles
(Freiman et al., 2001). Ovaries from adult non-hormone-treated
Taf4b null mice also have many fewer growing and antral
follicles (Fig. 7O) compared to wild type animals (Fig. 7N),
indicating that gene expression differences are not related to the
hormone treatments given in the previous study but rather
reflect the reduced number of follicles in Taf4b null mice.
Thus, the decreased expression of granulosa-cell-specific genes
in the study by Freiman et al. (2001) reflects the absence of
follicles (hence granulosa cells) rather than a decrease in gene
expression in granulosa cells per se. Thus, our studies extend
these previous results to document that, in younger mice,
granulosa cells do express granulosa-cell-specific genes in a
stage- and cell-specific manner during follicular development.
Genes known to be important to oocyte function including
Kit, Gdf9, Spin (Spindlin), Zar1, and Zfp393 were also
analyzed, and all were found to be normally expressed in the
ovaries of PMSG primed Taf4b null mice (Dong et al., 1996;
Oh et al., 1997; Wu et al., 2003; Yan et al., 2002). Since
microarray data indicated that expression of several genes was
altered in the testes of day 8 Taf4b null males and since several
genes involved in male germ cell stem cell function are
misexpressed in Taf4b null testes (Falender et al., 2005), we
hypothesized that TAF4b might have similar transcriptional
targets in the ovary. However, when many of the genes
misexpressed in Taf4b null testes were assayed including
Bard1, Jag2, Rara, Rarg, and Zbtb16 (Plzf), their expression
levels were at normal levels in PMSG primed Taf4b null
ovaries (Fig. 7M). c-Ret expression was not detected in wild
type, heterozygous, or Taf4b null ovaries (data not shown).Cumulus expansion is impaired in Taf4b null females
In order for ovulation to occur, the cumulus cells surround-
ing the oocyte must undergo expansion in which they migrate
and produce a hyaluronic acid (HA)-rich matrix that is
stabilized by HA-binding proteins. Cumulus expansion is
obligatory for both ovulation and fertilization (Richards et
al., 2002a). When immature Taf4b null females are hormonally
stimulated to ovulate, 50% fewer oocytes are present in the
oviduct compared to wild type and heterozygous animals (data
not shown). These results support previous studies showing
that ovulation is severely impaired in Taf4b null females
(Freiman et al., 2001). To examine the ovulation defect and
cumulus expansion in more detail, in vivo and in vitro
experiments were performed.
For the in vivo experiment, animals were treated with
PMSG followed by hCG. On the morning after hCG treatment
(24 h post-hCG), ovulated COCs were isolated from the
oviducts of heterozygous and Taf4b null animals. Isolated
COCs were immediately photographed. COCs isolated from
heterozygous animals contained several layers of cumulus cells
arranged in an expanded matrix and adherent to the oocyte
containing complex (Fig. 8A). Although expansion occurred in
some COCs isolated from Taf4b null animals, these complexes
contained fewer cumulus cells, and many were non-adherent to
the matrix (Fig. 8B).
For the in vitro experiment, wild type, heterozygous, and
Taf4b null animals were treated with PMSG for 44 h. Non-
expanded cumulus oocyte complexes (COCs) were collected
and cultured in the presence of serum with or without FSH, a
model well characterized to stimulate COC expansion in vitro
(Eppig et al., 1993; Ochsner et al., 2003a). In wild type and
Fig. 7. Several genes are expressed at normal levels in Taf4b null ovaries. In situ hybridization was performed on immature untreated (day 21) Taf4b heterozygous
(B) or null ovaries (D) using an antisense probe against inhibin bA. Green arrows indicate growing follicles. In situ hybridization was performed with antisense (F
and H) probes against Nr5a2 in PMSG hCG 2 h treated, heterozygous (F), or Taf4b null (H) ovaries and photographed using dark field microscopy. Large follicles
are indicated by black arrows. Follicles that did not respond to hormonal stimulation are indicated by white arrows. In situ hybridization was performed using an
antisense (I and K) probes against P450scc in heterozygous (I) or Taf4b null (K) ovaries of animals treated with PMSG and hCG for 48 h. Corresponding bright field
images are shown above. Semiquantitative RT-PCR was performed using RNA isolated from PMSG-treated animals using specific primer pairs against genes
expressed in somatic cells, oocyte-specific genes, and genes misexpressed in Taf4b null testes. Histological sections of ovaries of wild type (N) and Taf4b null mice
(O) mice are shown to document loss of follicles in the adult Taf4b null mice.
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COCs exhibited some expansion in response treatment with
FSH. However, expanded COCs contained notably fewer
cumulus cells (data not shown).
To provide semiquantitative data on the number of
cumulus cells in expanded COCs in culture, a classification
system was established in which COCs containing 10 or
more layers of cells were classified as ‘‘good’’, 2–9 layers
were classified as ‘‘poor,’’ and denuded oocytes were
classified as no expansion. Wild type and heterozygous
animals exhibited significantly more COCs classified as
good compared to Taf4b null animals (P < 0.01), whereas
Taf4b null animals exhibited significantly more COCs
classified as poor (P < 0.01) compared to wild type andheterozygous animals (Fig. 8C). These data provide evidence
that COC expansion is impaired in Taf4b null females.
There was not a significant difference in denuded oocytes in
all three groups because oocytes classified as no expansion
were most likely denuded during the isolation process and
do not relate to the phenotype of the animal.
During the process of cumulus expansion, several genes
are induced including those that encode matrix associated
factors Tnfaip6 (TSG-6) and Cspg2 (versican) (Ochsner et
al., 2003b; Russell et al., 2003). To determine if these genes
were properly induced in Taf4b null COCs, semiquantitative
RT-PCR was performed using RNA isolated from unex-
panded wild type COCs and expanded COCs from wild
type, heterozygous, and Taf4b null females. Both Tnfaip6
Fig. 8. Taf4b null cumulus oocyte complexes (COCs) exhibit abnormalities both in vitro and in vivo. Cumulus expansion is apparent in ovulated heterozygous COCs
(A). Ovulated Taf4b null COCs contain fewer cumulus cells (B). Unexpanded COCs were isolated from PMSG-treated animals and put in culture overnight with
FSH. On the next morning, the number of layers of COCs was counted and classified as follows: more than 10 layers (good expansion), 2–9 layers (expansion), 1–2
layers (poor expansion), denuded oocyte (no expansion) (C). Semiquantitative RT-PCR was performed for COC-specific genes including Tnfai6 and Cspg2 using
RNA isolated from COCs isolated from wild type, heterozygous, and Taf4b null animals prior to and after ovulation.
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COCs (Fig. 8D). Furthermore, Tnfaip6 induction is specific
to COCs and not detected in Taf4b null granulosa cells.
Thus, despite the overt histological abnormalities with Taf4b
null COCs, these genes known to be important to COC
function are properly induced.
Re-entry into meiosis is impaired in Taf4b null oocytes
To determine if meiotic resumption was intact in Taf4b null
females, COCs were isolated from superovulated wild type,
heterozygous, and Taf4b null females. Oocytes were denuded
by treatment with hyaluronidase and viewed by light micros-
copy to observe the status of the germinal vesicle and to
determine if the first polar body had been emitted. In wild type
and heterozygous animals, GVBD occurred in 99.2% and
99.1% respectively, whereas GVBD had occurred in only
85.7% of Taf4b null oocytes (P < 0.02, Fig. 9A). The first
polar body had been emitted from 90.2% to 94.1% of wild type
and heterozygous oocytes, respectively. In contrast, emission of
the first polar body was observed in only 45.9% of Taf4b null
oocytes (P < 0.001, Fig. 9A).
To determine if Taf4b null oocytes can form a proper
meiotic spindle, a hallmark of metaphase I and II, immunoflu-
orescence analyses were performed using antibodies against
acetylated tubulin, a marker of the meiotic spindle. In wild type
and heterozygous oocytes, a well-defined spindle was formed
in most of the oocytes observed (Fig. 9B). In some Taf4b null
oocytes, a well-defined spindle could be observed, but, in otheroocytes, this process was defective (Figs. 9C and D). The
percentage of oocytes with defects in spindle formation did not
exceed the percentage of oocytes unable to extrude a polar
body. This suggests that oocytes that properly extrude the first
polar body can form the meiotic spindle.
Fertilization occurs in Taf4b null oocytes, but embryos cannot
proceed beyond the 1-cell stage of development
Taf4b null females are completely infertile despite the
observations that they are able to ovulate and that some oocytes
achieve metaphase II of meiosis. We therefore hypothesized
that fertilization might be impaired in Taf4b null females. To
test this, immature, heterozygous, and Taf4b null females were
treated with PMSG followed by hCG. After treatment with
hCG, females were placed with wild type males, checked for
vaginal plugs, and COCs were removed from the oviducts 24
h later. Both male and female pronuclei were observed in
heterozygous and Taf4b null oocytes stained with DAPI and
tubulin, providing evidence that fertilization can occur in Taf4b
null oocytes (Figs. 9E and F).
To determine if early embryonic cleavage is intact in
zygotes from Taf4b females, females that had mated were
sacrificed 24 h later, oviducts were collected, and fertilized
oocytes were observed. In heterozygous animals, zygotes at the
2-cell stage of development were observed in the oviducts (Fig.
9G). At this stage of development, the two cells are of equal
size. In contrast, very few 2-cell stage zygotes were observed in
oocytes collected from the oviducts of Taf4b null mice. In the
Fig. 9. Re-entry into meiosis is impaired in Taf4b null oocytes, and zygotic development is blocked at the two-cell stage. COCs were isolated from superovulated
females 24 h after hCG treatment and denuded. The percentage of oocytes in which germinal vesicle breakdown (GVBD, left column) and the first polar body had
been emitted was counted (A). Oocytes from heterozygous (B) and Taf4b null (C and D) females were immunostained for tubulin (red) and stained with DAPI (blue).
Oocytes from heterozygous (E) and Taf4b null (F) females placed with males after hCG were immunostained for tubulin (red) and stained with DAPI (blue). White
arrows indicate pronuclei, and green arrows designate the sperm tail. Zygotes from heterozygous (G) and Taf4b (H) null females 24 h after plug observation were
collected and stained with Drac55 to visualize DNA or observed by light microscopy.
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rical. Commonly, completely disorganized fragmented zygotes
were observed (Fig. 9H). In wild type and heterozygous
animals, 4-cell stage zygotes were observed. No 4-cell stage
zygotes were observed in Taf4b null females. These data
provide evidence that fertilization in Taf4b null oocytes cannot
progress beyond the 2-cell stage.
Discussion
Targeted disruption of numerous genes has generated
infertile mice with cell- and stage-specific defects in ovarian
function. While disruption of some genes prevents follicle
formation, inactivation of others impairs follicular develop-
ment, ovulation, or luteinization (Jorgez et al., 2005). Thephenotype of female Taf4b null mice appears to be unique.
Specifically, defects in follicle formation are manifest as early
as postnatal day 3, a reduced number of follicles is present in
the adult, and resumption of meiosis and early cleavage steps
of ovulated and fertilized oocytes is impaired in the Taf4b null
mice. Although previous studies indicated that hormonally
primed Taf4b null adult females failed to express many
granulosa-cell-specific markers (Freiman et al., 2001), the data
presented herein extend these original observations to show
that the Taf4b null phenotype is more complex. Global
disruption of the genetic program in granulosa cells is not
observed. Rather, TAF4b impacts specific stages in early
follicular development and oocyte maturation.
Although an intense signal for TAF4b was observed in germ
cells compared to somatic cells of the embryonic (14.5 d.p.c.)
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primordial germ cells and female sex determination of the
gonad proceeded in the absence of TAF4b. The first phenotypic
abnormalities in the Taf4b null ovaries become evident
between postnatal day 0 and 3, when TAF4b protein remained
selectively expressed in the oocytes of developing follicles
compared to somatic cells. At this time, in the wild type ovary,
oocytes that are organized in germ cell cysts reorganize into
primordial follicles (Pepling and Spradling, 2001). This
reorganization process is impaired in the Taf4b null female
mice since the number of primordial follicles present in Taf4b
null ovaries on postnatal day 3 and day 8 is severely reduced.
These data indicate that TAF4b is among the first genes to be
identified that is important for this specific stage of early
follicle formation.
The cellular and molecular basis for this dramatic decrease
in the number of primordial follicles is not known. The
Taf4b null ovarian phenotype does not strictly match that
observed in other mouse models where disruption of selected
genes results in depletion of the oocytes at birth (Figa; Soyal
et al., 2000), rapid growth of oocytes (Foxo3; Castrillon et
al., 2003), aberrant follicle formation (Gdf-9; Dong et al.,
1996; Lfng; Hahn et al., 2005), or abnormal follicle growth
(Lhcgr ; Lei et al., 2001; Fshr ; Abel et al., 2000).
Furthermore, although TAF4b is expressed in germ cells of
male and female mice, the phenotype observed in the female
Taf4b null ovary does not appear to involve the same genes
or stages of germ cell development that are altered in the
Taf4b null male gonad. Whereas TAF4b is critical for
spermatogonial proliferation and specification between post-
natal day 0 and day 3 and is associated with reduced
expression of Stra8, Plzf (Zbtb1), and the Ret oncogene
(Ret) (Falender et al., 2005), levels of Stra8 and Plzf
transcripts are not disrupted in the Taf4b null ovary, and Ret
is not expressed at all.
Despite the presence of intense TAF4b staining in germ
cells between 14.5 d.p.c. and postnatal day 0 and day 3, no
germ-cell-specific gene has yet been identified as a potential
target of TAF4b. However, one among a plethora of somatic
cell marker examined was reduced in ovaries at Day 15; this
was Foxl2. Thus, Foxl2 is one possible target of Taf4b in
the ovary. This winged-helix (forkhead) transcription factor
is expressed in somatic cells of the embryonic and neonatal
gonad (Pisarska et al., 2004) and impacts early follicle
development. In ovaries of mice null for Foxl2, the
squamous granulosa cells surrounding oocytes of primordial
follicles do not become cuboidal, resulting in an arrest in
folliculogenesis and premature ovarian failure (Ottolenghi et
al., 2005; Schmidt et al., 2004; Uda et al., 2004). However,
ovarian development in the Taf4b null mice does not
phenocopy precisely the severe alterations in follicle
formation observed in the Foxl2 null mice. This may be
due to the fact that Foxl2 expression is reduced but not
completely absent in the Taf4b ovary. The mechanisms by
which Foxl2 might impact early follicle formation in the
Taf4b null mice are not known but may involve bi-
directional interactions between the somatic cells andoocytes. Since Foxl2 mRNA is expressed predominantly in
granulosa cells and in these cells overlaps with that of Taf4b
(Freiman et al., 2001), a factor derived from somatic cells
may impact oocyte development/function. Such a mechanism
has recently been proposed for the role of lunatic fringe
(Lfng) that impacts early follicle formation and meiosis,
presumably by altering the function of the Notch-Jagged1
signaling pathway occurring between the cumulus cells and
the oocyte (Hahn et al., 2005). Conversely, since at these
early stages of follicular growth, intense staining of TAF4b
protein occurred in oocytes compared to that in somatic
cells, an oocyte-derived factor may impact expression of
Foxl2 mRNA in somatic cells. Although the identify of such
a factor has not yet been determined, this factor is unlikely
to be GDF9 since levels of this growth factor are normal in
the Taf4b null oocytes. The observation that Foxl2 mRNA
is reduced in heterozygous ovaries is difficult to understand
because no overt phenotypic abnormalities have been
detected in these mice. There may be subtle changes in
follicle development that we have not observed. Alterna-
tively, factors (not yet identified) in addition to Foxl2 are
likely to be essential for the Taf4b null phenotype, and
changes in these factors may not occur in the heterozygote.
Despite the defects observed in Taf4b null ovaries between
day 0 and day 3, follicles are able to develop beyond the
primary stage, albeit in reduced numbers and with fewer
granulosa cells, and ovulate in response to exogenous
hormones. Furthermore, many genes expressed in granulosa
cells during follicular development, such as Cyp19a1, Foxo1a,
Nr5a, Nr5a2, and Fshr, are detected in ovaries of Taf4b null
mice at levels similar to those in ovaries of wild type and
heterozygous littermates. Thus, granulosa cell differentiation
and responsiveness to FSH are not completely disrupted in
immature mice as previously reported for older mice (Freiman
et al., 2001). That levels of cyclin D2 mRNA are essentially
normal in the Taf4b null ovaries indicates that altered
expression of other cell cycle regulators or specific growth
factors may account for the reduced granulosa cell number in
Taf4b null follicles. That ovulation can be induced in the Taf4b
null females and that these mice mate indicates that many
aspects of follicular cell function and the coincident hormo-
nally induced behavioral events are normal. In addition,
cumulus expansion, a complex process during which cumulus
cells surrounding the oocyte produce a matrix rich in
hyaluronan and hyaluronan-binding proteins such as TNFAIP6
and CSPG2 (Ochsner et al., 2003b; Richards et al., 2002a;
Varani et al., 2002; Zhuo et al., 2001), occurs in Taf4b null
COCs despite the markedly reduced number of cumulus cells
within the expanded matrix.
Although a few of the ovulated Taf4b null oocytes progress
to metaphase II of meiosis, many Taf4b null oocytes fail to
proceed properly through meiosis as shown by the decreased
percentage of oocytes completing germinal vesicle breakdown,
emitting the first polar body and forming a proper meiotic
spindle. During meiosis, chromatin becomes condensed as the
meiotic spindle forms. During this time, many global chroma-
tin modifications occur including histone phosphorylation,
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Hooser et al., 1998). Other TAFs have been shown to associate
with chromatin modifying enzymes in the TFTC complex
(TBP free TAF containing complex) (Brand et al., 1999; Muller
and Tora, 2004; Wieczorek et al., 1998). One intriguing
possibility is that TAF4b associates with chromatin modifying
enzymes and in this manner is important for cellular activities
other than transcription.
The observation that zygotic development of fertilized
oocytes from Taf4b null females cannot progress beyond the
2-cell stage is of interest because this is around the time at
which zygotic genome activation (ZGA) occurs (Hamatani et
al., 2004). During ZGA, maternal transcripts are degraded as
the embryonic genome begins actively transcribing genes
(Nothias et al., 1995). During this transition, major chromatin
remodeling occurs (Wiekowski et al., 1997), and the carboxy
terminus of RNA polymerase II becomes hypo-phosphorylat-
ed to promote active transcription (Bellier et al., 1997;
Usheva et al., 1992). In 1-cell embryos, enhancer function
is silenced and cannot be restored even when supplied with
potent transcriptional activators such as Gal4:VP16, SP1, or
the transcription factor TEF1 (Lawinger et al., 1999;
Majumder et al., 1997; Usheva et al., 1992). Enhancer
function is restored upon ZGA in the 2-cell embryo. This
restoration of ZGA has been hypothesized to be mediated by
a cell-type-specific co-activator or TAF (Nothias et al., 1995).
Perhaps TAF4b is a potential candidate for this Funknown
TAF._
In summary, female mice null for Taf4b exhibit a unique
infertile phenotype characterized by defects in early follicle
formation evident as early as postnatal day 3, follicle cell
proliferation that is independent of changes in cyclin D2, and
resumption of meiosis followed by a block in the development
of Taf4b null zygotes around the time of the 2-cell stage of
development. Since TAF4b is expressed in germ cells as well
as somatic cells and since it is known to be regulated both at
the transcriptional and posttranscriptional levels, deciphering
the precise function of this factor in germ cells versus somatic
cells will depend on the development of more sophisticated
reagents and greater understanding of the role of the TAF
complex in germ cells and somatic cells.
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